Print Page   |   Contact Us   |   Your Cart   |   Sign In
Sign In

Forgot your password?

Haven't registered yet?

Breaking News
News & Press: Daily Updates

Gavi, Merck ink Ebola vaccine purchase agreement

Wednesday, January 20, 2016   (0 Comments)

Gavi, the Vaccine Alliance, and Merck have signed a purchase agreement worth $5 million to push the VSV-EBOV Ebola vaccine through initial licensing and to stockpile enough for clinical trials and emergency use.


OSAP Disclaimer | Please notify our webmaster of any problems with this website.
OSAP thanks its Super Sponsors for their support in 2016. Sponsorship does not imply endorsement by OSAP of a company's products or services.